Switching to Alemtuzumab in MS, Keep Washout to a Minimum Switching to Alemtuzumab in MS, Keep Washout to a Minimum

Two new studies of patients switching from natalizumab or fingolimod to alemtuzumab suggest that shorter washout periods are better to reduce disease reactivation.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news